Cargando…

Signatures of malignant cells and novel therapeutic targets revealed by single‐cell sequencing in lung adenocarcinoma

BACKGROUND: Single‐cell transcriptomics has been used to investigate various tumors to elucidate the molecular distinction of all cell type compositions of a complex mix. AIMS: This study aimed to investigate malignant‐cell‐specific genes to explore diagnostic and therapeutic biomarkers using single...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jiaqi, Chen, Zhencong, Huang, Yiwei, Bi, Guoshu, Bian, Yunyi, Jin, Xing, Zhang, Huan, Sui, Qihai, Zhan, Cheng, Wang, Qun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160812/ https://www.ncbi.nlm.nih.gov/pubmed/35102706 http://dx.doi.org/10.1002/cam4.4547

Ejemplares similares

HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway
por: Liang, Jiaqi, et al.
Publicado: (2023)

Identification of the relationship between single-cell N6-methyladenosine regulators and the infiltrating immune cells in esophageal carcinoma
por: Bian, Yunyi, et al.
Publicado: (2023)

Genetic and microenvironmental differences in non-smoking lung adenocarcinoma patients compared with smoking patients
por: Sui, Qihai, et al.
Publicado: (2020)

The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data
por: Sui, Qihai, et al.
Publicado: (2023)

Correction to: The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data
por: Sui, Qihai, et al.
Publicado: (2023)

Cisplatin resistance-related multi-omics differences and the establishment of machine learning models
por: Sui, Qihai, et al.
Publicado: (2022)

Characterization of Infiltrating Immune Cells and Secretory or Membrane-Associated Proteins in KRAS Lung Adenocarcinoma
por: Bian, Yunyi, et al.
Publicado: (2023)

Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas
por: Jin, Xing, et al.
Publicado: (2021)

Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma
por: Zhao, Mengnan, et al.
Publicado: (2022)

miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways
por: Bi, Guoshu, et al.
Publicado: (2022)

Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma
por: Hu, Zhengyang, et al.
Publicado: (2023)

Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinoma
por: Chen, Zhencong, et al.
Publicado: (2020)

A nomogram to predict prognosis of patients with lung adenosquamous carcinoma: a population-based study
por: Liang, Jiaqi, et al.
Publicado: (2020)

Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo
por: Bi, Guoshu, et al.
Publicado: (2021)

The clinical prognostic factors of patients with stage IB lung adenocarcinoma
por: Sui, Qihai, et al.
Publicado: (2021)

Identification and Validation of a Proliferation-Associated Score Model Predicting Survival in Lung Adenocarcinomas
por: Bian, Yunyi, et al.
Publicado: (2021)

Long-term outcomes following neoadjuvant or adjuvant chemoradiotherapy for stage I–IIIA non-small cell lung cancer: a propensity-matched analysis
por: Xi, Junjie, et al.
Publicado: (2020)

Tumor-Associated Regulatory T Cells in Non-Small-Cell Lung Cancer: Current Advances and Future Perspectives
por: Liang, Jiaqi, et al.
Publicado: (2022)

Compare the efficacy and safety of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) inhibitors for advanced non-small cell lung cancer: a Bayesian analysis
por: Liang, Jiaqi, et al.
Publicado: (2020)

Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma
por: Chen, Zhencong, et al.
Publicado: (2021)

Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy
por: Chen, Zhencong, et al.
Publicado: (2021)

Analysis of the differences in lung cancer research trends between China and the United States based using project funding data
por: Zheng, Yuansheng, et al.
Publicado: (2021)

Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets
por: Bi, Guoshu, et al.
Publicado: (2021)

Hepatic nuclear factor 4 alpha promotes the ferroptosis of lung adenocarcinoma via transcriptional activation of cytochrome P450 oxidoreductase
por: Besskaya, Valeria, et al.
Publicado: (2023)

Landscape and dynamics of single tumor and immune cells in early and advanced‐stage lung adenocarcinoma
por: Chen, Zhencong, et al.
Publicado: (2021)

Single-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodules
por: Lu, Tao, et al.
Publicado: (2020)

Enlarged Mediastinal Lymph Nodes in Computed Tomography are a Valuable Prognostic Factor in Non-Small Cell Lung Cancer Patients with Pathologically Negative Lymph Nodes
por: Zheng, Yuansheng, et al.
Publicado: (2020)

LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma
por: Chen, Zhencong, et al.
Publicado: (2022)

A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for Lung Adenocarcinoma
por: Jin, Xing, et al.
Publicado: (2022)

Identification and validation of the mitochondrial function related hub genes by unsupervised machine learning and multi-omics analyses in lung adenocarcinoma
por: Jin, Xing, et al.
Publicado: (2022)

Genomic And Tumor Microenvironment Differences Between Cell Cycle Progression Pathway Altered/Non-Altered Patients With Lung Adenocarcinoma
por: Shan, Guangyao, et al.
Publicado: (2022)

Inhibition of PKA/CREB1 pathway confers sensitivity to ferroptosis in non-small cell lung cancer
por: Shan, Guangyao, et al.
Publicado: (2023)

Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma
por: Zhang, Huan, et al.
Publicado: (2021)

Multi-Omics Analysis of Cancer Cell Lines with High/Low Ferroptosis Scores and Development of a Ferroptosis-Related Model for Multiple Cancer Types
por: Shan, Guangyao, et al.
Publicado: (2021)

The Prognostic Value Of Lymph Node Ratio In Patients With N2 Stage Lung Squamous Cell Carcinoma: A Nomogram And Heat Map Approach
por: Bi, Guoshu, et al.
Publicado: (2019)

HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer
por: Huang, Yiwei, et al.
Publicado: (2021)

Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies
por: Xue, Liang, et al.
Publicado: (2020)

Reconstructing the Developmental Trajectories of Multiple Subtypes in Pulmonary Parenchymal Epithelial Cells by Single-Cell RNA-seq
por: Huang, Yiwei, et al.
Publicado: (2020)

Weighted Correlation Network Analysis of Cancer Stem Cell-Related Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma
por: Zhao, Mengnan, et al.
Publicado: (2022)

The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Bi, Guoshu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7bmtt1ni47ra1llltd83ia7nr2